InvestorsHub Logo
Followers 9
Posts 920
Boards Moderated 0
Alias Born 04/21/2014

Re: MD-420 post# 15763

Saturday, 02/04/2017 3:13:27 PM

Saturday, February 04, 2017 3:13:27 PM

Post# of 37540
Since OMHE named its CEO, they are working very fast: both past due 10-Qs are out; OTC confirmed OMHE is "current" and instead of releasing another PR, OMHE CEO stated in 17Q2 PR that OMHE is immediately seeking uplist from OTCPink to OTCQB - so this will be done soon too

OMHE Chief Executive Officer Andrey Soloviev stated, "More important than the numbers reflected in the quarterly report is OMHE becoming current in its filings. We will immediately seek to move from OTC Pink to OTCQB. We thank our shareholders for their patience during this transition."



Since management is working fast and CEO is well qualified, hence imo, their business plan will be solid:


Mr. Soloviev is a performance driven seasoned Health Care Executive and Entrepreneur. Having earned his Bachelor of Science degree in 2001 from Touro University in New York, Andrey has more than 15 years of notable success executing strategic healthcare projects. He is an exceptional leader and expert in management of health services operations, planning, execution, and regulatory compliance. In 2008 he became the CEO of Malecon Pharmacy, a wholly owned subsidiary of OMHE. Mr. Soloviev was instrumental in the expansion of services converting Malecon Pharmacy into a Specialty Pharmacy Service Company. He has expanded the scope of the anti-aging specialty business from regional operations to a large international enterprise.



OMHE PPS will keep rising as there have been solid income numbers, status is "current", uplist to OTCQB is imminent and qualified management will strengthen the business, imo! Next week PPS Forecast ~ 10cents